ArticlePathogens (Basel, Switzerland)2020

Efficacy Evaluation of Two Commercial Vaccines Against a Recombinant PRRSV2 Strain ZJnb16-2 From Lineage 8 and 3 in China.

Guangwei Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.